High blood pressure:

You’re not alone. Under the latest guidelines, about 45.4% of US adults have high blood pressure.1*

That means more Americans than ever before are living with this condition.1 EDARBI and EDARBYCLOR are powerful choices for you and your doctor to consider.2,3
*95% confidence interval of 43.9%-46.9% and 101.9-108.8 million US adults.1 Based on a comparison of adults living with hypertension in 2014 vs. 2017.1

Take Control With
a Powerful ARB

EDARBI is an ARB that may reduce your blood pressure. Clinical studies have shown Edarbi is more effective in lowering blood pressure than Benicar® (olmesartan medoxomil) or Diovan® (valsartan).2

Abbreviation: ARB = angiotension II receptor blocker

Get To Know EDARBI

Take Control With a
Powerful ARB + Diuretic

If a single medication hasn’t helped lower your blood pressure, EDARBYCLOR may be the answer. EDARBYCLOR showed statistically superior blood pressure control vs Benicar HCT® (olmesartan medoxomil-hydrochlorothiazide) in a head-to-head study.3

Get To Know EDARBYCLOR

Learn More About
High Blood Pressure

And What You Can Do to Take Control

Millions of people just like you are monitoring and managing their blood pressure every day. Learn about causes, risks, guidelines, and more—and find a guide to taking your own blood pressure.

Start learning now

Save on EDARBI and EDARBYCLOR, Whatever Your INSURANCE Coverage

No matter what your current insurance coverage is, we have programs that may help you get the prescription treatment you need at a cost you can afford. Even if you’re between insurance or underinsured right now, we have programs to help you get access to the prescriptions you need.
Click here to see our prescription savings programs

START SAVING NOW: ANSWER ONE SIMPLE QUESTION

Click below to discover which savings program is best for you.
Find your savings program
  1. Bundy JD, Mills KT, Chen J, Li C, Greenland P, He J. Estimating the Association of the 2017 and 2014 Hypertension Guidelines With Cardiovascular Events and Deaths in US Adults: An Analysis of National Data. JAMA Cardiol. 2018;3(7):572-581.
  2. White WB, Weber MA, Sica D, et al. Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension. Hypertension. 2011;57(3):413-420.
  3. Cushman WC, Bakris GL, White WB, et al. Azilsartan medoxomil plus chlorthalidone reduces blood pressure more effectively than olmesartan plus hydrochlorothiazide in stage 2 systolic hypertension. Hypertension. 2012;60(2):310-318.

INDICATIONS

EDARBI is a prescription medicine used to treat high blood pressure (hypertension) in adults and EDARBYCLOR is a prescription medicine used to treat high blood pressure (hypertension). Your doctor may prescribe other medicines for you to take along with EDARBI or EDARBYCLOR to treat your high blood pressure. EDARBYCLOR is used when one medicine is not enough or as the first medicine if your doctor decides you are likely to need more than one medicine. Medicines that lower your blood pressure may lower your chances of having a stroke or heart attack, but they don’t work alone. They should be part of a complete treatment plan.

IMPORTANT SAFETY INFORMATION

WARNING: EDARBI® and EDARBYCLOR® can cause harm or death to your unborn baby. If you become pregnant while taking EDARBI or EDARBYCLOR, tell your doctor right away. If you plan to become pregnant, talk to your doctor about other treatments to lower blood pressure.
  • Before taking EDARBI or EDARBYCLOR, tell your doctor if you are breastfeeding or plan to breastfeed. Discuss with your doctor other ways to lower your blood pressure. Breastfeeding while taking EDARBI or EDARBYCLOR is not recommended.
  • Do not take EDARBYCLOR if you make less urine because of kidney problems (anuria).
  • Do not take aliskiren-containing products with EDARBI or EDARBYCLOR if you have diabetes.
  • Tell your doctor about all your medical conditions, including if you have heart problems or stroke, have gout, or have liver or kidney problems. Kidney problems may become worse in people that already have kidney disease. If you have kidney problems, you may need blood tests, and your doctor may need to lower your dose or may need to stop treatment with EDARBYCLOR. During treatment with EDARBI or EDARBYCLOR, certain people who have severe heart failure, narrowing of the artery to the kidney, or who lose too much body fluid such as with nausea, vomiting, bleeding, or trauma, may develop sudden kidney failure and in rare instances, death.
  • Tell your doctor about all the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements. Especially tell your doctor if you take other medicines to treat your high blood pressure or heart problem; water pills (diuretics); lithium; or digoxin.
  • EDARBI and EDARBYCLOR may cause serious side effects, including low blood pressure (hypotension) which may cause you to feel faint or dizzy. Vomiting and diarrhea, a low salt diet, sweating a lot, or not drinking enough fluid can also lead to low blood pressure.
  • If you feel faint or dizzy, lie down and call your doctor right away. If you pass out (faint), have someone call your doctor or get medical help. Stop taking EDARBYCLOR.
  • If you have fluid and body salt (electrolyte) problems, tell your doctor if you experience any of the following symptoms: dry mouth, confusion, thirst, lack of energy (lethargic), weakness, drowsiness, passing very little urine or passing large amounts of urine, seizures, muscle pain/cramps, restlessness, muscle tiredness (fatigue), fast or abnormal heartbeat, nausea and vomiting, or constipation.
  • People who have increased levels of uric acid in the blood may develop gout. If you already have gout, tell your doctor about worsening of your gout symptoms.
  • In clinical studies, the most common side effect seen with EDARBI was diarrhea (2.0%).
  • In a clinical study, the side effects seen with EDARBYCLOR included dizziness (8.9%) and tiredness (2.0%).

The Important Safety Information does not include all the information needed to use EDARBI and EDARBYCLOR safely and effectively.

For further information, please see accompanying complete Prescribing Information for EDARBI and EDARBYLCOR.

To report SUSPECTED ADVERSE REACTIONS, contact Azurity Pharmaceuticals, Inc. at 1-800-461-7449 or to the FDA at www.fda.gov/medwatch or call 1-800-FDA-1088.

PP-EDB-US-0665